Go Pro
Leonid Timashev

Leonid Timashev Analyst Performance

Vice President, Biotechnology Analyst at Royal Bank Of Canada

Leonid Timashev is a stock analyst at Royal Bank Of Canada focused in the healthcare sector, covering 28 publicly traded companies. Over the past year, Leonid Timashev has issued 109 stock ratings, including buy and hold recommendations. While full access to Leonid Timashev's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Leonid Timashev's coverage history, rating activity, and performance tendencies - helping individual investors make more informed trading decisions.

Analyst Rankings, Coverage, and Performance Statistics

Average Return
00.00% 12-Month ROI
Success Rate
00.00% Profitable Ratings
Total Ratings
142 Last 1 Years
Buy Recommendations
88.73% 126 Buy Ratings
Companies Covered
28 Unique Companies

Ratings Distribution

RatingPercentageCount
Strong Buy0.0%0 ratings
Buy88.7%126 ratings
Hold11.3%16 ratings
Sell0.0%0 ratings

Out of 142 total stock ratings issued by Leonid Timashev at Royal Bank Of Canada, the majority (88.7%) have been Buy recommendations, followed by 11.3% Hold.

Exchange Coverage

ExchangePercentageCount
NASDAQ
82.1% of companies on NASDAQ
23 companies
NYSE
14.3% of companies on NYSE
4 companies
NYSEAMERICAN
3.6% of companies on NYSEAMERICAN
1 company

Leonid Timashev, an analyst at Royal Bank Of Canada, currently covers 28 companies listed on NASDAQ, NYSE and NYSEAMERICAN, with the majority traded on NASDAQ.

Coverage Focus

Sector IconSectorPercentage
Healthcare
27 companies
96.4%
Consumer Staples
1 company
3.6%

Leonid Timashev of Royal Bank Of Canada specializes in stock coverage within the Healthcare sector, with additional focus on Consumer Staples companies.

Coverage Industries

IndustryPercentage
BIOTECHNOLOGY
20 companies
71.4%
PHARMACEUTICALS
7 companies
25.0%
FOOD PRODUCTS
1 company
3.6%

Leonid Timashev's Ratings History at Royal Bank Of Canada

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription
12-Month ROIUpgrade to All Access to use the All ROI Filter
CompanyReport DateActionReport Date Price12-Month
Price Target
Rating12-Month
Price & ROI
Details
Praxis Precision Medicines, Inc. stock logo
PRAX
Praxis Precision Medicines
8/7/2026Reiterated Rating$369.00$462.00Outperform
Nuvation Bio Inc. stock logo
NUVB
Nuvation Bio
8/7/2026Boost Price Target$6.42$20.00Outperform
Cytokinetics, Incorporated stock logo
CYTK
Cytokinetics
8/7/2026Lower Price Target$79.08$112.00Outperform
CG Oncology, Inc. stock logo
CGON
CG Oncology
8/7/2026Lower Price Target$74.11$79.00Outperform
Xencor, Inc. stock logo
XNCR
Xencor
8/6/2026Boost Price Target$19.84$20.00Outperform
Revolution Medicines, Inc. stock logo
RVMD
Revolution Medicines
8/6/2026Boost Price Target$197.30$203.00Outperform
Compass Pathways PLC Sponsored ADR stock logo
CMPS
Compass Pathways
8/6/2026Lower Price Target$13.58$21.00Outperform
BeOne Medicines Ltd. - Sponsored ADR stock logo
ONC
BeOne Medicines
8/6/2026Lower Price Target$326.58$450.00Outperform
NewAmsterdam Pharma Company N.V. stock logo
NAMS
NewAmsterdam Pharma
8/6/2026Lower Price Target$27.63$50.00Outperform
Legend Biotech Corporation Sponsored ADR stock logo
LEGN
Legend Biotech
7/27/2026Lower Price Target$19.43$59.00Outperform
Nuvation Bio Inc. stock logo
NUVB
Nuvation Bio
7/22/2026Reiterated Rating$6.26Outperform
Verastem, Inc. stock logo
VSTM
Verastem
7/7/2026Set Price Target$4.47$14.00Outperform
Nuvation Bio Inc. stock logo
NUVB
Nuvation Bio
7/7/2026Lower Price Target$5.81$19.00Outperform
Legend Biotech Corporation Sponsored ADR stock logo
LEGN
Legend Biotech
7/7/2026Lower Price Target$28.04$63.00Outperform
IDEAYA Biosciences, Inc. stock logo
IDYA
IDEAYA Biosciences
7/7/2026Lower Price Target$39.37$48.00Outperform
Exelixis, Inc. stock logo
EXEL
Exelixis
7/7/2026Boost Price Target$55.53$46.00Sector Perform
Cytokinetics, Incorporated stock logo
CYTK
Cytokinetics
7/7/2026Lower Price Target$86.21$117.00Outperform
BeOne Medicines Ltd. - Sponsored ADR stock logo
ONC
BeOne Medicines
7/7/2026Boost Price Target$309.46$451.00Outperform
Axsome Therapeutics, Inc. stock logo
AXSM
Axsome Therapeutics
7/7/2026Boost Price Target$242.60$304.00Outperform
CorMedix Inc stock logo
CRMD
CorMedix
7/7/2026Lower Price Target$8.85$13.00Outperform
NewAmsterdam Pharma Company N.V. stock logo
NAMS
NewAmsterdam Pharma
6/30/2026Boost Price Target$33.87$51.00Outperform
Praxis Precision Medicines, Inc. stock logo
PRAX
Praxis Precision Medicines
6/17/2026Initiated Coverage$270.01$449.00Outperform
Edgewise Therapeutics, Inc. stock logo
EWTX
Edgewise Therapeutics
6/17/2026Boost Price Target$34.10$59.00Outperform
Cytokinetics, Incorporated stock logo
CYTK
Cytokinetics
6/17/2026Reiterated Rating$75.21$119.00Outperform
Praxis Precision Medicines, Inc. stock logo
PRAX
Praxis Precision Medicines
6/17/2026Upgrade$282.31Moderate Buy
Alkermes plc stock logo
ALKS
Alkermes
6/9/2026Boost Price Target$44.09$56.00Outperform
Insmed, Inc. stock logo
INSM
Insmed
6/5/2026Lower Price Target$104.92$195.00Outperform
ADC Therapeutics SA stock logo
ADCT
ADC Therapeutics
6/4/2026Downgrade$3.07$2.00Sector Perform
Edgewise Therapeutics, Inc. stock logo
EWTX
Edgewise Therapeutics
6/2/2026Lower Price Target$38.56$48.00Outperform
Revolution Medicines, Inc. stock logo
RVMD
Revolution Medicines
6/2/2026Boost Price Target$156.54$182.00Outperform
BeOne Medicines Ltd. - Sponsored ADR stock logo
ONC
BeOne Medicines
6/2/2026Boost Price Target$279.44$436.00Outperform
Jasper Therapeutics, Inc. stock logo
JSPR
Jasper Therapeutics
5/15/2026Set Price Target$0.82$3.00Sector Perform
Compass Pathways PLC Sponsored ADR stock logo
CMPS
Compass Pathways
5/14/2026Boost Price Target$11.02$22.00Outperform
Legend Biotech Corporation Sponsored ADR stock logo
LEGN
Legend Biotech
5/13/2026Boost Price Target$28.64$64.00Outperform
CG Oncology, Inc. stock logo
CGON
CG Oncology
5/11/2026Boost Price Target$70.52$81.00Outperform
Insmed, Inc. stock logo
INSM
Insmed
5/8/2026Lower Price Target$99.15$205.00Outperform
Revolution Medicines, Inc. stock logo
RVMD
Revolution Medicines
5/7/2026Boost Price Target$144.32$165.00Outperform
BeOne Medicines Ltd. - Sponsored ADR stock logo
ONC
BeOne Medicines
5/7/2026Boost Price Target$314.90$425.00Outperform
Cytokinetics, Incorporated stock logo
CYTK
Cytokinetics
5/6/2026Boost Price Target$75.19$119.00Outperform
Jazz Pharmaceuticals PLC stock logo
JAZZ
Jazz Pharmaceuticals
5/6/2026Boost Price Target$224.32$258.00Outperform
Barricks gold output fell from 2 million ounces to 719000 (Ad)

Barrick's gold production has plunged from 2 million ounces to just 719,000, leaving the world's second-largest miner running on fumes. Newmont's $15 billion purchase of Newcrest, the largest mining deal in history, still couldn't keep output growing, proof that majors must keep buying to survive. With record cash flows and shrinking mines, gold majors are positioned to launch a wave of acquisitions targeting the best junior assets.tc pixel

See the top three gold buyout targets to watch now
Axsome Therapeutics, Inc. stock logo
AXSM
Axsome Therapeutics
5/5/2026Boost Price Target$228.88$302.00Outperform
ADC Therapeutics SA stock logo
ADCT
ADC Therapeutics
5/5/2026Reiterated Rating$3.77$6.00Outperform
Biohaven Ltd. stock logo
BHVN
Biohaven
5/5/2026Lower Price Target$9.37$22.00Outperform
Nuvation Bio Inc. stock logo
NUVB
Nuvation Bio
5/5/2026Reiterated Rating$4.72$20.00Outperform
BRC Inc. stock logo
BRCC
BRC
5/5/2026Reiterated Rating$1.30$2.50Buy
CorMedix Inc stock logo
CRMD
CorMedix
4/28/2026Reiterated Rating$7.82$14.00Outperform
CG Oncology, Inc. stock logo
CGON
CG Oncology
4/27/2026Boost Price Target$69.57$79.00Outperform
IDEAYA Biosciences, Inc. stock logo
IDYA
IDEAYA Biosciences
4/14/2026Boost Price Target$32.82$53.00Outperform
Insmed, Inc. stock logo
INSM
Insmed
4/14/2026Boost Price Target$151.14$216.00Outperform
Bicycle Therapeutics PLC Sponsored ADR stock logo
BCYC
Bicycle Therapeutics
3/18/2026Lower Price Target$4.63$7.00Sector Perform
Perspective Therapeutics, Inc. stock logo
CATX
Perspective Therapeutics
3/17/2026Lower Price Target$4.88$14.00Outperform
Legend Biotech Corporation Sponsored ADR stock logo
LEGN
Legend Biotech
3/11/2026Lower Price Target$20.21$62.00Outperform
Design Therapeutics, Inc. stock logo
DSGN
Design Therapeutics
3/10/2026Boost Price Target$10.54$14.00Outperform
Nuvation Bio Inc. stock logo
NUVB
Nuvation Bio
3/3/2026Boost Price Target$4.53$13.00Outperform
Biohaven Ltd. stock logo
BHVN
Biohaven
3/3/2026Boost Price Target$10.87$23.00Outperform
Exelixis, Inc. stock logo
EXEL
Exelixis
3/2/2026Lower Price Target$41.07$43.00Sector Perform
BeOne Medicines Ltd. - Sponsored ADR stock logo
ONC
BeOne Medicines
2/26/2026Boost Price Target$322.37$425.00Outperform
Alkermes plc stock logo
ALKS
Alkermes
2/26/2026Lower Price Target$30.33$45.00Outperform
Jazz Pharmaceuticals PLC stock logo
JAZZ
Jazz Pharmaceuticals
2/25/2026Boost Price Target$192.05$195.00Outperform
Axsome Therapeutics, Inc. stock logo
AXSM
Axsome Therapeutics
2/24/2026Boost Price Target$170.33$222.00Outperform
Cytokinetics, Incorporated stock logo
CYTK
Cytokinetics
2/20/2026Boost Price Target$67.66$101.00Outperform
Compass Pathways PLC Sponsored ADR stock logo
CMPS
Compass Pathways
2/18/2026Boost Price Target$7.63$22.00Outperform
IDEAYA Biosciences, Inc. stock logo
IDYA
IDEAYA Biosciences
2/18/2026Reiterated Rating$30.75$49.00Outperform
Exelixis, Inc. stock logo
EXEL
Exelixis
2/11/2026Boost Price Target$42.01$46.00Sector Perform
Compass Pathways PLC Sponsored ADR stock logo
CMPS
Compass Pathways
1/23/2026Boost Price Target$7.40$21.00Outperform
Nuvation Bio Inc. stock logo
NUVB
Nuvation Bio
1/21/2026Boost Price Target$6.00$12.00Outperform
NewAmsterdam Pharma Company N.V. stock logo
NAMS
NewAmsterdam Pharma
1/21/2026Boost Price Target$32.41$47.00Outperform
Insmed, Inc. stock logo
INSM
Insmed
1/21/2026Boost Price Target$163.51$200.00Outperform
IDEAYA Biosciences, Inc. stock logo
IDYA
IDEAYA Biosciences
1/21/2026Boost Price Target$35.75$45.00Outperform
CorMedix Inc stock logo
CRMD
CorMedix
1/21/2026Set Price Target$6.88$13.00Outperform
CG Oncology, Inc. stock logo
CGON
CG Oncology
1/21/2026Boost Price Target$54.69$73.00Outperform
Axsome Therapeutics, Inc. stock logo
AXSM
Axsome Therapeutics
1/21/2026Boost Price Target$184.50$219.00Outperform
Cytokinetics, Incorporated stock logo
CYTK
Cytokinetics
1/21/2026Reiterated Rating$64.68$95.00Outperform
Legend Biotech Corporation Sponsored ADR stock logo
LEGN
Legend Biotech
1/20/2026Reiterated Rating$23.39$66.00Outperform
Cytokinetics, Incorporated stock logo
CYTK
Cytokinetics
12/22/2025Boost Price Target$62.72$95.00Outperform
Pyxis Oncology, Inc. stock logo
PYXS
Pyxis Oncology
12/18/2025Lower Price Target$1.73$5.00Outperform
Insmed, Inc. stock logo
INSM
Insmed
12/18/2025Lower Price Target$198.46$195.00Outperform
BeOne Medicines Ltd. - Sponsored ADR stock logo
ONC
BeOne Medicines
12/17/2025Reiterated Rating$307.91Outperform
Legend Biotech Corporation Sponsored ADR stock logo
LEGN
Legend Biotech
12/8/2025Reiterated Rating$24.54$74.00Outperform
Design Therapeutics, Inc. stock logo
DSGN
Design Therapeutics
11/20/2025Upgrade$7.34$13.00Outperform
BeOne Medicines Ltd. - Sponsored ADR stock logo
ONC
BeOne Medicines
11/18/2025Boost Price Target$360.68$408.00Outperform
Jazz Pharmaceuticals PLC stock logo
JAZZ
Jazz Pharmaceuticals
11/17/2025Set Price Target$170.34$194.00Outperform
CG Oncology, Inc. stock logo
CGON
CG Oncology
11/17/2025Boost Price Target$41.01$61.00Outperform
Legend Biotech Corporation Sponsored ADR stock logo
LEGN
Legend Biotech
11/13/2025Lower Price Target$31.39$74.00Outperform
Cytokinetics, Incorporated stock logo
CYTK
Cytokinetics
11/11/2025Boost Price Target$63.66$87.00Outperform
BeOne Medicines Ltd. - Sponsored ADR stock logo
ONC
BeOne Medicines
11/7/2025Boost Price Target$314.09$395.00Outperform
Edgewise Therapeutics, Inc. stock logo
EWTX
Edgewise Therapeutics
11/7/2025Boost Price Target$17.30$50.00Outperform
Design Therapeutics, Inc. stock logo
DSGN
Design Therapeutics
11/6/2025Boost Price Target$6.46$6.00Sector Perform
Biohaven Ltd. stock logo
BHVN
Biohaven
11/6/2025Lower Price Target$8.44$9.00Sector Perform
Xencor, Inc. stock logo
XNCR
Xencor
11/6/2025Boost Price Target$14.61$19.00Outperform
Here’s the stock symbol I’ve promised (Ad)

Whitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - but now he believes he's found something better. This under-the-radar company sits at the intersection of America's two most important industries, including AI, pays massive dividends, and attracted a famous money manager who put 60% of his multi-billion-dollar fund into it. Tilson is revealing the name and ticker symbol completely free - no credit card or email required.tc pixel

Get the stock name and ticker symbol free of charge today
NewAmsterdam Pharma Company N.V. stock logo
NAMS
NewAmsterdam Pharma
11/6/2025Boost Price Target$37.24$44.00Outperform
Jazz Pharmaceuticals PLC stock logo
JAZZ
Jazz Pharmaceuticals
11/6/2025Boost Price Target$133.08$155.00Outperform
Nuvation Bio Inc. stock logo
NUVB
Nuvation Bio
11/4/2025Boost Price Target$4.78$8.00Outperform
Axsome Therapeutics, Inc. stock logo
AXSM
Axsome Therapeutics
11/4/2025Boost Price Target$132.75$198.00Outperform
Revolution Medicines, Inc. stock logo
RVMD
Revolution Medicines
11/3/2025Initiated Coverage$58.84$77.00Outperform
Insmed, Inc. stock logo
INSM
Insmed
10/31/2025Boost Price Target$192.36$215.00Outperform
Bicycle Therapeutics PLC Sponsored ADR stock logo
BCYC
Bicycle Therapeutics
10/31/2025Reiterated Rating$8.76$11.00Sector Perform
Bicycle Therapeutics PLC Sponsored ADR stock logo
BCYC
Bicycle Therapeutics
10/31/2025Downgrade$8.07$11.00Sector Perform
Xencor, Inc. stock logo
XNCR
Xencor
10/27/2025Boost Price Target$14.05$18.00Outperform
Alkermes plc stock logo
ALKS
Alkermes
10/22/2025Boost Price Target$31.09$47.00Outperform
IDEAYA Biosciences, Inc. stock logo
IDYA
IDEAYA Biosciences
10/21/2025Boost Price Target$30.51$41.00Outperform
Exelixis, Inc. stock logo
EXEL
Exelixis
10/21/2025Reiterated Rating$35.17$45.00Sector Perform
Verastem, Inc. stock logo
VSTM
Verastem
10/20/2025Set Price Target$8.35$13.00Outperform
Alkermes plc stock logo
ALKS
Alkermes
9/26/2025Upgrade$27.13$44.00Outperform
IDEAYA Biosciences, Inc. stock logo
IDYA
IDEAYA Biosciences
9/9/2025Boost Price Target$24.08$38.00Outperform
Jazz Pharmaceuticals PLC stock logo
JAZZ
Jazz Pharmaceuticals
8/28/2025Boost Price Target$124.38$151.00Outperform
Xencor, Inc. stock logo
XNCR
Xencor
8/21/2025Lower Price Target$7.38$15.00Outperform
Legend Biotech Corporation Sponsored ADR stock logo
LEGN
Legend Biotech
8/12/2025Reiterated Rating$37.38$77.00Outperform
Bicycle Therapeutics PLC Sponsored ADR stock logo
BCYC
Bicycle Therapeutics
8/11/2025Set Price Target$7.57$27.00Outperform
Insmed, Inc. stock logo
INSM
Insmed
8/8/2025Boost Price Target$109.19$120.00Outperform
Edgewise Therapeutics, Inc. stock logo
EWTX
Edgewise Therapeutics
8/8/2025Boost Price Target$12.76$49.00Outperform
Verastem, Inc. stock logo
VSTM
Verastem
8/8/2025Boost Price Target$6.79$13.00Outperform
Nuvation Bio Inc. stock logo
NUVB
Nuvation Bio
8/8/2025Boost Price Target$2.37$7.00Outperform
NewAmsterdam Pharma Company N.V. stock logo
NAMS
NewAmsterdam Pharma
8/7/2025Boost Price Target$22.71$39.00Outperform
BeOne Medicines Ltd. - Sponsored ADR stock logo
ONC
BeOne Medicines
8/7/2025Boost Price Target$296.70$364.00Outperform
Axsome Therapeutics, Inc. stock logo
AXSM
Axsome Therapeutics
8/5/2025Boost Price Target$106.54$189.00Outperform
Alkermes plc stock logo
ALKS
Alkermes
7/30/2025Boost Price Target$27.11$42.00Sector Perform
Exelixis, Inc. stock logo
EXEL
Exelixis
7/29/2025Lower Price Target$37.20$45.00Sector Perform
Bicycle Therapeutics PLC Sponsored ADR stock logo
BCYC
Bicycle Therapeutics
7/17/2025Lower Price Target$7.85$25.00Outperform
CG Oncology, Inc. stock logo
CGON
CG Oncology
7/16/2025Lower Price Target$25.36$53.00Outperform
BeOne Medicines Ltd. - Sponsored ADR stock logo
ONC
BeOne Medicines
7/16/2025Boost Price Target$276.52$349.00Outperform
IDEAYA Biosciences, Inc. stock logo
IDYA
IDEAYA Biosciences
7/9/2025Upgrade$21.45$30.00Moderate Buy
Verastem, Inc. stock logo
VSTM
Verastem
6/25/2025Upgrade$4.44$12.00Moderate Buy
CorMedix Inc stock logo
CRMD
CorMedix
6/20/2025Upgrade$13.76$17.00Moderate Buy
ADC Therapeutics SA stock logo
ADCT
ADC Therapeutics
6/20/2025Upgrade$3.07$5.00Moderate Buy
Nuvation Bio Inc. stock logo
NUVB
Nuvation Bio
6/17/2025Upgrade$1.79$6.00Moderate Buy
Axsome Therapeutics, Inc. stock logo
AXSM
Axsome Therapeutics
6/12/2025Lower Price Target$107.04$186.00Outperform
Edgewise Therapeutics, Inc. stock logo
EWTX
Edgewise Therapeutics
6/5/2025Reiterated Rating$14.25$48.00Outperform
Perspective Therapeutics, Inc. stock logo
CATX
Perspective Therapeutics
6/3/2025Upgrade$3.21$16.00Moderate Buy
Biohaven Ltd. stock logo
BHVN
Biohaven
5/19/2025Downgrade$16.07$21.00Sector Perform
Biohaven Ltd. stock logo
BHVN
Biohaven
5/13/2025Lower Price Target$19.39$54.00Outperform
Axsome Therapeutics, Inc. stock logo
AXSM
Axsome Therapeutics
4/29/2025Boost Price Target$110.82$193.00Outperform
Edgewise Therapeutics, Inc. stock logo
EWTX
Edgewise Therapeutics
4/3/2025Lower Price Target$12.77$52.00Outperform
Pyxis Oncology, Inc. stock logo
PYXS
Pyxis Oncology
3/19/2025Reiterated Rating$1.07$8.00Outperform
BRC Inc. stock logo
BRCC
BRC
3/19/2025Reiterated Rating$2.12$3.00Buy
Alkermes plc stock logo
ALKS
Alkermes
3/13/2025Initiated Coverage$33.41$40.00Sector Perform
Biohaven Ltd. stock logo
BHVN
Biohaven
3/4/2025Reiterated Rating$30.42$61.00Outperform
Edgewise Therapeutics, Inc. stock logo
EWTX
Edgewise Therapeutics
3/4/2025Reiterated Rating$25.09$56.00Outperform
Insmed, Inc. stock logo
INSM
Insmed
2/25/2025Initiated Coverage$80.03$100.00Outperform
Axsome Therapeutics, Inc. stock logo
AXSM
Axsome Therapeutics
2/19/2025Boost Price Target$127.42$192.00Outperform
The cat is out the bag (Ad)

Almost 80,000 tech jobs vanished in the first three months of 2026. Meta cut 14,000 roles, Microsoft offered separation packages to 8,500 workers, and Oracle is reportedly eliminating up to 30,000 positions. Goldman Sachs estimates 12,400 Americans are being financially displaced every single day. Analyst Porter Stansberry says the real driver runs deeper than AI - and two Nobel Prize winners have issued the same warning. He calls it the Final Displacement, and he's releasing a full investigation with specific companies to buy and sell before the next wave hits.tc pixel

Watch Porter Stansberry's full investigation into the Final Displacement now
NewAmsterdam Pharma Company N.V. stock logo
NAMS
NewAmsterdam Pharma
1/24/2025Reiterated Rating$23.67$40.00Outperform
Incyte Corporation stock logo
INCY
Incyte
1/23/2025Reiterated Rating$72.24$70.00Sector Perform